{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:31:55Z","timestamp":1793035915328,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.medmal.2017.09.012","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T21:01:54Z","timestamp":1508360514000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection"],"prefix":"10.1016","volume":"48","author":[{"given":"M.","family":"Bruyand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mariani-Kurkdjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gouali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"de Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Le Hello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bonacorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Loirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8325","key":"10.1016\/j.medmal.2017.09.012_bib0355","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(83)91795-6","article-title":"Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools","volume":"1","author":"Karmali","year":"1983","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.medmal.2017.09.012_bib0360","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM198303243081203","article-title":"Hemorrhagic colitis associated with a rare Escherichia coli serotype","volume":"308","author":"Riley","year":"1983","journal-title":"N Engl J Med"},{"issue":"9464","key":"10.1016\/j.medmal.2017.09.012_bib0365","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.medmal.2017.09.012_bib0370","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.medmal.2017.09.012_bib0375","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.medmal.2017.09.012_bib0380","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","article-title":"Hemolytic uremic syndrome","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"19","key":"10.1016\/j.medmal.2017.09.012_bib0385","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1106483","article-title":"Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany","volume":"365","author":"Frank","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.medmal.2017.09.012_bib0390","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/fpd.2012.1401","article-title":"Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections","volume":"10","author":"Gould","year":"2013","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.medmal.2017.09.012_bib0395","unstructured":"ECDC ECDC surveillance report. Surveillance of seven priorities food-waterborne diseases in the EU\/EEA 2010\u20132012. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/food-and-waterborne-diseases-surveillance-report-2015.pdf. Accessed on December 7, 2016."},{"issue":"9","key":"10.1016\/j.medmal.2017.09.012_bib0400","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3201\/eid2209.160304","article-title":"Enterohemorrhagic Escherichia coli Hybrid Pathotype O80:H2 as a new therapeutic challenge","volume":"22","author":"Soysal","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.medmal.2017.09.012_bib0405","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.lpm.2012.10.010","article-title":"[Enterohemorragic Escherichia coli (EHEC): topical enterobacteriaceae]","volume":"42","author":"Gouali","year":"2013","journal-title":"Presse Med"},{"key":"10.1016\/j.medmal.2017.09.012_bib0410","first-page":"195","article-title":"Shiga toxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies","volume":"6","author":"Keir","year":"2012","journal-title":"Drug Des Devel Ther"},{"issue":"11","key":"10.1016\/j.medmal.2017.09.012_bib0415","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nrneph.2012.196","article-title":"Renal and neurological involvement in typical Shiga toxin-associated HUS","volume":"8","author":"Trachtman","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.medmal.2017.09.012_bib0420","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1172\/JCI57313","article-title":"The CXCR4\/CXCR7\/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice","volume":"122","author":"Petruzziello-Pellegrini","year":"2012","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.medmal.2017.09.012_bib0425","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.hoc.2015.01.007","article-title":"Shiga toxin associated hemolytic uremic syndrome","volume":"29","author":"Keir","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.medmal.2017.09.012_bib0430","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1016\/j.medmal.2017.09.012_bib0435","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00467-013-2561-1","article-title":"Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome","volume":"29","author":"Keir","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1016\/j.medmal.2017.09.012_bib0440","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1681\/ASN.2013050450","article-title":"Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement","volume":"25","author":"Locatelli","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.medmal.2017.09.012_bib0445","doi-asserted-by":"crossref","first-page":"e1004619","DOI":"10.1371\/journal.ppat.1004619","article-title":"A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles","volume":"11","author":"Stahl","year":"2015","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.medmal.2017.09.012_bib0450","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.4049\/jimmunol.1402470","article-title":"Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome","volume":"194","author":"Arvidsson","year":"2015","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.medmal.2017.09.012_bib0455","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.medmal.2017.09.012_bib0460","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molimm.2013.11.009","article-title":"Interaction of Shiga toxin 2 with complement regulators of the factor H protein family","volume":"58","author":"Poolpol","year":"2014","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.medmal.2017.09.012_bib0465","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J Immunol"},{"issue":"46","key":"10.1016\/j.medmal.2017.09.012_bib0470","doi-asserted-by":"crossref","first-page":"33118","DOI":"10.1074\/jbc.M113.487413","article-title":"Interaction of Shiga toxin with the A-domains and multimers of von Willebrand Factor","volume":"288","author":"Lo","year":"2013","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.medmal.2017.09.012_bib0475","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/fpd.2013.1704","article-title":"Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis","volume":"11","author":"Majowicz","year":"2014","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.medmal.2017.09.012_bib0705","series-title":"Surveillance du syndrome h\u00e9molytique et ur\u00e9mique post-diarrh\u00e9ique chez l\u2019enfant de moins de 15ans en France en 2015","author":"Bruyand","year":"2016"},{"issue":"Suppl 5","key":"10.1016\/j.medmal.2017.09.012_bib0485","doi-asserted-by":"crossref","first-page":"S424","DOI":"10.1093\/cid\/cis208","article-title":"Strategies for surveillance of pediatric hemolytic uremic syndrome: foodborne diseases active surveillance network (FoodNet), 2000\u20132007","volume":"54","author":"Ong","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.medmal.2017.09.012_bib0490","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00431-015-2642-1","article-title":"Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network","volume":"175","author":"Ardissino","year":"2016","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.medmal.2017.09.012_bib0495","series-title":"Zoonotic agents and food-borne outbreaks in 2013","article-title":"The European Union summary report on trends and sources of zoonoses","author":"European Union","year":"2013"},{"issue":"4","key":"10.1016\/j.medmal.2017.09.012_bib0500","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/fpd.2010.0673","article-title":"Escherichia coli O157:H7: animal reservoir and sources of human infection","volume":"8","author":"Ferens","year":"2011","journal-title":"Foodborne Pathog Dis"},{"issue":"7","key":"10.1016\/j.medmal.2017.09.012_bib0505","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/INF.0b013e3181993731","article-title":"Undercooked ground beef and person-to-person transmission as major risk factors for sporadic hemolytic uremic syndrome related to Shiga-toxin producing Escherchia coli infections in children in France","volume":"28","author":"Vaillant","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.medmal.2017.09.012_bib0510","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijheh.2016.10.011","article-title":"Transmission pathways for sporadic Shiga-toxin producing E. coli infections: a systematic review and meta-analysis","volume":"220","author":"Kintz","year":"2017","journal-title":"Int J Hyg Environ Health"},{"issue":"3","key":"10.1016\/j.medmal.2017.09.012_bib0515","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3201\/eid1703.100167","article-title":"Escherichia coli O157 infection and secondary spread, Scotland, 1999\u20132008","volume":"17","author":"Locking","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.medmal.2017.09.012_bib0520","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1017\/S0950268808001490","article-title":"Community-wide outbreak of Escherichia coli O157:H7 associated with consumption of frozen beef burgers","volume":"137","author":"King","year":"2009","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.medmal.2017.09.012_bib0525","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3201\/eid2204.151485","article-title":"Shiga toxin-producing Escherichia coli O157, England and Wales, 1983\u20132012","volume":"22","author":"Adams","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.medmal.2017.09.012_bib0530","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/cid\/cis255","article-title":"Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011","volume":"54","author":"King","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"Suppl 112","key":"10.1016\/j.medmal.2017.09.012_bib0535","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/ki.2008.616","article-title":"Factors that led to the Walkerton tragedy","volume":"75","author":"Salvadori","year":"2009","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.medmal.2017.09.012_bib0540","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1017\/S0950268811002111","article-title":"Large outbreak of verocytotoxin-producing Escherichia coli O157 infection in visitors to a petting farm in South East England, 2009","volume":"140","author":"Ihekweazu","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.medmal.2017.09.012_bib0545","series-title":"Gastroent\u00e9rites \u00e0 Escherichia coli ent\u00e9roh\u00e9morragique. Conduite \u00e0 tenir","author":"Haut Conseil de la Sant\u00e9 Publique","year":"2015"},{"issue":"1","key":"10.1016\/j.medmal.2017.09.012_bib0550","doi-asserted-by":"crossref","first-page":"e2050","DOI":"10.1097\/MD.0000000000002050","article-title":"Recurrent hemolytic and uremic syndrome induced by Escherichia coli","volume":"95","author":"Commereuc","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.medmal.2017.09.012_bib0555","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/cis196","article-title":"Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae","volume":"54","author":"Rosales","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2017.09.012_bib0560","first-page":"1","article-title":"Recommendations for diagnosis of Shiga toxin\u00a0\u2013\u00a0producing Escherichia coli infections by clinical laboratories","volume":"58","author":"Gould","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.medmal.2017.09.012_bib0565","first-page":"3138","article-title":"Scientific Opinion on VTEC\u00a0\u2013\u00a0seropathotype and scientific criteria regarding pathogenicity assessment","volume":"11","author":"EFSA","year":"2013","journal-title":"EFSA J"},{"issue":"11","key":"10.1016\/j.medmal.2017.09.012_bib0570","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1128\/JCM.01066-15","article-title":"Utility of whole-genome sequencing of Escherichia coli O157 for outbreak detection and epidemiological surveillance","volume":"53","author":"Holmes","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.medmal.2017.09.012_bib0575","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1128\/JCM.03617-13","article-title":"Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli","volume":"52","author":"Joensen","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.medmal.2017.09.012_bib0580","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s00467-016-3420-7","article-title":"Fecal diagnostics in combination with serology: best test to establish STEC-HUS","volume":"31","author":"Wijnsma","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"10.1016\/j.medmal.2017.09.012_bib0585","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1128\/JCM.00817-11","article-title":"Point: Should all stools be screened for Shiga toxin-producing Escherichia coli?","volume":"49","author":"Marcon","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.medmal.2017.09.012_bib0590","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jpeds.2014.12.064","article-title":"Postdiarrheal hemolytic uremic syndrome in United States children: clinical spectrum and predictors of in-hospital death","volume":"166","author":"Mody","year":"2015","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.medmal.2017.09.012_bib0595","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2215\/CJN.08921209","article-title":"Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome","volume":"5","author":"Nathanson","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.medmal.2017.09.012_bib0600","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/brain\/aws090","article-title":"The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak","volume":"135","author":"Magnus","year":"2012","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.medmal.2017.09.012_bib0605","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1086\/644621","article-title":"Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000\u20132006","volume":"49","author":"Gould","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.medmal.2017.09.012_bib0610","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.medmal.2017.09.012_bib0615","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00467-008-0799-9","article-title":"Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome","volume":"23","author":"Oakes","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.medmal.2017.09.012_bib0620","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00467-014-2918-0","article-title":"Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome","volume":"30","author":"Ardissino","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.medmal.2017.09.012_bib0625","doi-asserted-by":"crossref","first-page":"e20152153","DOI":"10.1542\/peds.2015-2153","article-title":"Early volume expansion and outcomes of hemolytic uremic syndrome","volume":"137","author":"Ardissino","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2017.09.012_bib0630","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","article-title":"Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study","volume":"345","author":"Menne","year":"2012","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.medmal.2017.09.012_bib0635","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.288.8.996","article-title":"Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis","volume":"288","author":"Safdar","year":"2002","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.medmal.2017.09.012_bib0640","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/cid\/ciw099","article-title":"Shiga toxin-producing Escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome: a meta-analysis","volume":"62","author":"Freedman","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.medmal.2017.09.012_bib0645","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/jac\/dkv162","article-title":"Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposal","volume":"70","author":"Agger","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.medmal.2017.09.012_bib0650","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/cid\/cis299","article-title":"Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis","volume":"55","author":"Wong","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.medmal.2017.09.012_bib0655","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/INF.0b013e31823096a8","article-title":"Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota","volume":"31","author":"Smith","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.medmal.2017.09.012_bib0660","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.2012.264","article-title":"Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4","volume":"307","author":"Nitschke","year":"2012","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.medmal.2017.09.012_bib0665","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/cid\/cis1218","article-title":"Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study","volume":"56","author":"Vonberg","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.medmal.2017.09.012_bib0670","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.ajkd.2008.07.038","article-title":"Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials","volume":"53","author":"Michael","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.medmal.2017.09.012_bib0675","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","article-title":"Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry","volume":"27","author":"Kielstein","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"9797","key":"10.1016\/j.medmal.2017.09.012_bib0680","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(11)61253-1","article-title":"Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial","volume":"378","author":"Greinacher","year":"2011","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.medmal.2017.09.012_bib0685","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.medmal.2017.09.012_bib0690","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ndt\/gft470","article-title":"Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab","volume":"29","author":"Delmas","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.medmal.2017.09.012_bib0695","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0009922814534520","article-title":"Response to Eculizumab in Escherichia coli O157: H7-induced hemolytic uremic syndrome with severe neurological manifestations","volume":"54","author":"Saini","year":"2015","journal-title":"Clin Pediatr (Phila)"},{"issue":"24","key":"10.1016\/j.medmal.2017.09.012_bib0700","doi-asserted-by":"crossref","first-page":"e1000","DOI":"10.1097\/MD.0000000000001000","article-title":"Eculizumab in typical hemolytic uremic syndrome (HUS) with neurological involvement","volume":"94","author":"Pape","year":"2015","journal-title":"Medicine (Baltimore)"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X16308599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X16308599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:15:58Z","timestamp":1759972558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X16308599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0399077X16308599"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2017.09.012","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2017.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}